The pan immune inflammatory value in relation to non-alcoholic fatty liver disease and hepatic fibrosis

This publication has 30 references indexed in Scilit:

• The global syndemic of metabolic diseases in the young adult population: A consortium of trends and projections from the Global Burden of Disease 2000–2019
  Metabolism, 2023
• Prediction of immune-related adverse events in non-small cell lung cancer patients treated with immune checkpoint inhibitors based on clinical and hematological markers: Real-world evidence
  Experimental Cell Research, 2022
• Prevalence of Liver Steatosis and Fibrosis Detected by Transient Elastography in Adolescents in the 2017–2018 National Health and Nutrition Examination Survey
  Clinical Gastroenterology and Hepatology, 2021
• Transient Versus Two‐Dimensional Shear‐Wave Elastography in a Multistep Strategy to Detect Advanced Fibrosis in NAFLD
  Hepatology, 2020
• Metformin modulates innate immune-mediated inflammation and early progression of NAFLD-associated hepatocellular carcinoma in zebrafish
  Journal of Hepatology, 2019
• Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease
  Clinical Gastroenterology and Hepatology, 2019
• Disruption of tumor necrosis factor alpha receptor 1 signaling accelerates NAFLD progression in mice upon a high-fat diet
  The Journal of Nutritional Biochemistry, 2018
• Innate Immunity and Inflammation in NAFLD/NASH
  Digestive Diseases and Sciences, 2016
• Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2
  Journal of Hepatology, 2006
• Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
  Hepatology, 2006